| Financial Year |
March 31 2023 |
| Monetary Funds |
788,037,050.54 |
| Held-for-trading Financial Assets |
3,222,000.00 |
| Notes Receivable |
561,928,880.35 |
| Accounts Receivable |
1,247,376,226.64 |
| Advances to Suppliers |
64,858,545.02 |
| Other Receivables |
415,980,617.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,040,897,852.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,426,732.73 |
| Total Current Assets |
4,351,621,553.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
284,075,937.04 |
| Investment Properties |
14,700,337.62 |
| Fixed Assetes |
887,903,746.72 |
| Under-construction Projects |
680,590,034.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
429,147,672.76 |
| R&D expenses |
262,961,685.26 |
| Goodwill |
334,105,881.07 |
| Long-Term Deferred and Prepaid Expenses |
69,273,792.88 |
| Deferred Income Tax Assets |
184,030,913.50 |
| Other Non-Current Assets |
29,537,761.01 |
| Sub-Total of Non-Current Assets |
3,569,349,620.64 |
| Total Assets |
7,920,971,174.63 |
| Short-Term Loans |
699,461,735.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,470,250.02 |
| Accounts Payable |
1,834,192,669.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
126,692,480.24 |
| Taxes Payable |
35,406,364.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
205,175,428.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
192,925,212.82 |
| Other Current Liabilities |
1,244,983.25 |
| Sub-Total of Current Liabilities |
3,226,842,011.79 |
| Long-term Loans |
112,133,673.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,629,222,439.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,667,166.62 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,910,509,847.52 |
| Total Liabilities |
5,137,351,859.31 |
| Paid-In Capital(Or Share Stock) |
604,490,017.00 |
| Capital Surplus |
2,455,741,818.08 |
| Surplus Reserve |
75,151,125.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-377,467,359.79 |
| Minority Stockholder's Interest |
-8,577,775.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,792,197,090.33 |
| Owner's Equity（Stockholder's Equity） |
2,783,619,315.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,920,971,174.63 |
